Stay updated with breaking news from Mark Hegarty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical-stage diagnostics spin-out Dxcover has raised almost £10 million for its novel technology for early detection of multiple cancers, founded on research carried out at the University of Strathclyde. Click to read more...
'Liquid biopsy' technique aimed at early-stage cancer diagnosis via algorithmic analysis of infrared spectra.
A GLASGOW-based company developing a blood test aimed at detecting cancer at an early stage has raised £9.7 million
Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!